openPR Logo
Press release

PREMIER Biosoft and PamGene International B.V. form an alliance

02-20-2007 07:16 PM CET | IT, New Media & Software

Press release from: PREMIER Biosoft International

Palo Alto, California—February 15th 2007. PREMIER Biosoft International, a leading bioinformatics company, and PamGene International B.V., owner of patented technologies for second-generation microarray products, have come together to develop a software tool to design custom oligos for use in MLPA® based assays.

Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method for assessing tens to hundreds of gene copy number changes, single-nucleotide polymorphisms (SNPs), insertions and deletions and methylation markers in genomic DNA in a single reaction tube. PamGene’s microarray platform detects and quantifies all these MLPA® amplified products with a single array using its flow-through PamChip® microarrays and PamStation® systems.

The alliance will help MLPA® users design custom oligos for use with PamGene's microarrays. Currently, such a tool is not available to the users. "I see great synergies between the two companies. I look forward to working with PamGene to develop such an innovative product", commented Kay Brown, V.P. Business Development and Marketing of PREMIER Biosoft. Rinie van Beuningen, V.P. Business Development, PamGene International added, “With this software tool we are enabling researchers to quickly develop new multiplex genomic assays for use in research and diagnostics”.

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.

About PamGene International
PamGene is a European biotechnology company that owns patented technologies for second-generation microarray products including an innovative transcription profiling system. Its array-based MLPA application, based on Jan Schouten’s discovery in 2002 and using reagents provided by MRC-Holland, accelerates a number of genomic assays. PamGene’s technology and products are for use in pharma-biotech R&D and production, academic research, non-pharma life sciences and health management testing applications. More information about PamGene International can be found at http://www.pamgene.com/

Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com

PREMIER Biosoft International
3786, Corina Way, Palo Alto
California, USA
Phone: 650-856-2703
Fax: 650-618-1773
Email: support@premierbiosoft.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PREMIER Biosoft and PamGene International B.V. form an alliance here

News-ID: 16021 • Views: 1400

More Releases from PREMIER Biosoft International

PREMIER Biosoft Announces Reseller Agreement with Bruker to Advance Lipidomics a …
PREMIER Biosoft, a next generation leader in bioinformatics, and Bruker Corporation (NASDAQ: BRKR) today announced that they have entered a reselling agreement pursuant to which Bruker will co-market and resell Premier's SimLipid and SimMet, high throughput informatics tools for lipid and metabolite data analysis. Integration with Bruker's mass spectrometric workflows will enable new powerful ways for researchers to seamlessly generate, process, and analyze data. Bruker's instruments produce highly accurate broad
PREMIER Biosoft Delivers Version 2.0 of OligoEvaluator™ to Sigma Life Science
Palo Alto, California -- PREMIER Biosoft, delivered OligoEvaluator™ 2.0 to Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich. Sigma-Aldrich, a leading Life Science and High Technology company conducts operations in 37 countries and provides biochemical and organic chemical products for scientific and genomic research. The new release of OligoEvaluator™ offers analysis of physico-chemical properties of multiple DNA or RNA sequences in a single search run
PREMIER Biosoft announces the release of SimGlycan® Enterprise Edition 5.0 to s …
Palo Alto, California : PREMIER Biosoft, a next generation leader in bioinformatics, today announced the release of Enterprise Edition of SimGlycan® v. 5.0, a comprehensive high throughput tool to provide support for glycan quantitation using Thermo Scientific™ aminoxyTMT™ for MS/MS glycan data analysis workflows. Additionally, it can be used for processing of LC-MS data for peak detection, peak picking and alignment of glycans based on retention time, precursor m/z
PREMIER Biosoft announces the release of SimGlycan® v. 5.0 to provide informati …
Palo Alto, California – May 21, 2014: PREMIER Biosoft, a next generation leader in bioinformatics today announced the release of a new version of SimGlycan®, a comprehensive, high throughput tool to provide automated informatics support for LC-MS and MS/MS glycan data analysis workflows. The new version of the software facilitates processing of LC-MS and MS/MS data for peak detection, peak picking and alignment of glycans based on retention time, precursor

All 5 Releases


More Releases for PamGene

DNA and Gene Chip (Microarrays) Market Brief Analysis By Regions, Top Key Player …
The Global DNA and Gene Chip (Microarrays) Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 13.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast by 2024. Global DNA and Gene Chip Market Report focuses on the major drivers and restraints for the key players. The
Global DNA and Gene Chip (Microarrays) Market business development strategies ti …
DNA and Gene Chip (Microarrays) market research report offers valuable insights and helps client’s gain higher market share into multiple sections impacting the growth of the market globally. For a better understanding of the market, our market experts provide a comprehensive analysis of the factors defining the the growth of the DNA and Gene Chip (Microarrays) market and encompasses a wide range of factors that will prove crucial to our
Biomarkers Global Market 2018: Key Players – Agendia, Agilent Technologies, In …
Biomarkers Industry Description Wiseguyreports.Com Adds “Biomarkers -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database Biomarkers Market research report focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil,
Global DNA and Gene Chip (Microarrays) Market 2018 Key Trends, Segmentation, App …
Microarrays are used to conduct many tests on biological material like DNA very quickly and without using up much material. Microarrays can be used to detect proteins, DNA, RNA, antibodies, carbohydrates, or other chemical compounds, although DNA microarrays are the most commonly used today. Microarrays have revolutionized DNA analysis, allowing the expression levels of many genes to be measured at the same time. Microarray technology is used to analyze the gene
Global DNA and Gene Chip (Microarrays) Market Size, Share, Growth, Trends, Type, …
The Global DNA and Gene Chip (Microarrays) Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 13.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Major market drivers and restraints: • Huge Amount of DNA/ Gene Chip Initiatives • Need For Initial Cancer Detection & Cancer
Recent Research Report on “The Global DNA And Gene Chip Market 2018” CAGR of …
The Global DNA And Gene Chip (Microarrays) Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 13.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Market Definition: Global DNA and Gene Chip (Microarrays) Market Microarray technology is used to analyze the gene expression